Financial analyst and writer of “The Cannabis Report” Ted Ohashi talks about some news affecting the cannabis world, some news that will affect Khiron (TSXV: KHRN) (OTCQX: KHRNF), and Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP). Both Khiron and Lexaria are companies in his model portfolio.

0:11 Introduction
0:48 Cannabis News
3:02 News Affecting Khiron
3:40 Lexaria Bioscience
6:25 Final Thoughts

The Cannabis Report: https://ih.advfn.com/newsletters/cannabisreport/

Khiron:

https://ih.advfn.com/stock-market/TSXV/KHRN/stock-price

https://ih.advfn.com/stock-market/USOTC/khiron-life-sciences-qx-KHRNF/stock-price

Lexaria Bioscience:

https://ih.advfn.com/stock-market/USOTC/lexaria-bioscience-qx-LXRP/stock-price

https://ih.advfn.com/stock-market/CNSX/LXX/stock-price

Website: https://investorshub.advfn.com/

Investors Hub Twitter: https://twitter.com/Investors_Hub

Talk with me on the Market Vision forum: https://investorshub.advfn.com/Investors-Hub-Market-Vision-38574/

Investors Hub LinkedIn: https://www.linkedin.com/company/investorshub-com-inc-

Investors Hub Facebook: https://www.facebook.com/InvestorsHub

source